Evidence map›Paper›PMID 38344146›Full record

ArticleStatistics and its interface2023

Estimating individualized treatment rules for multicategory type 2 diabetes treatments using electronic health records.

Jitong Lou, Yuanjia Wang, Lang Li, Donglin Zeng

Abstract read
In one paragraph

Article in Statistics and its interface, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jitong Lou135 Dauer Drive, 3101 McGavran-Greenberg Hall, Chapel Hill, NC 27599, USA.
Yuanjia Wang722 West 168th Street, Rm 210, New York, NY 10032, USA.
Lang Li250 Lincoln Tower, 1800 Cannon Drive, Columbus, OH 43210, USA.
Donglin Zeng135 Dauer Drive, 3103B McGavran-Greenberg Hall, Chapel Hill, NC 27599, USA.

Funding

Statistical Methods for Integrating Mixed-type Biomarkers and Phenotypes in Neurodegenerative Disease ModelingR01NS073671 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WANG, YUANJIA · 2011 to 2025
$3.9M
Statistical and Machine Learning Methods to Improve Dynamic Treatment Regimens Estimation Using Real World Data.R01GM124104 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Yuanjia Wang, Donglin Zeng · 2018 to 2026
$3.1M
Machine Learning Methods for Optimizing Individualized Treatment Strategies for Precision PsychiatryR01MH123487 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WANG, YUANJIA · 2021 to 2025
$2.0M
Integrative Learning to Combine Evidence for Personalized Treatment Strategies.R21MH117458 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WANG, YUANJIA · 2018 to 2019
$446k
NIGMS NIH HHS R01 GM124104NIMH NIH HHS R01 MH123487NIMH NIH HHS R21 MH117458NINDS NIH HHS R01 NS073671
6 · The paper itself

Abstract

In this article, we propose a general framework to learn optimal treatment rules for type 2 diabetes (T2D) patients using electronic health records (EHRs). We first propose a joint modeling approach to characterize patient's pretreatment conditions using longitudinal markers from EHRs. The estimation accounts for informative measurement times using inverse-intensity weighting methods. The predicted latent processes in the joint model are used to divide patients into a finite of subgroups and, within each group, patients share similar health profiles in EHRs. Within each patient group, we estimate optimal individualized treatment rules by extending a matched learning method to handle multicategory treatments using a one-versus-one approach. Each matched learning for two treatments is implemented by a weighted support vector machine with matched pairs of patients. We apply our method to estimate optimal treatment rules for T2D patients in a large sample of EHRs from the Ohio State University Wexner Medical Center. We demonstrate the utility of our method to select the optimal treatments from four classes of drugs and achieve a better control of glycated hemoglobin than any one-size-fits-all rules.

Indexed as

Electronic health recordsIndividualized treatment rulesLatent processMachine learningMulticategory treatmentsType 2 diabetes

Identifiers

PMID38344146
PMCPMC10857856

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.